XOI: 1-[(5M,8aS,13R)-5-[6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl]-6-chloro-2-{[(2S,4R)-4-fluoro-1-methylpyrrolidin-2-yl]methoxy}-8a,9,11,12-tetrahydropyrazino[2',1':3,4][1,4]oxazepino[5,6,7-de]quinazolin-10(8H)-yl]prop-2-en-1-one
XOI is a Ligand Of Interest in 8UN3 designated by the Author
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8UN3_XOI_A_201 | 100% | 50% | 0.019 | 0.997 | 0.64 | 1.16 | 1 | 4 | 0 | 0 | 100% | 1 |
| 8UN3_XOI_C_201 | 100% | 48% | 0.019 | 0.997 | 0.73 | 1.16 | 2 | 4 | 1 | 0 | 100% | 1 |
| 8UN3_XOI_B_201 | 100% | 56% | 0.022 | 0.996 | 0.58 | 0.9 | 1 | 3 | 1 | 0 | 100% | 1 |
| 8UN3_XOI_D_201 | 100% | 50% | 0.023 | 0.996 | 0.67 | 1.1 | 1 | 3 | 0 | 0 | 100% | 1 |
